MENU
+Compare
EPRX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$3.20
Change
+$0.19 (+6.31%)
Capitalization
114.56M

EPRX Eupraxia Pharmaceuticals Forecast, Technical & Fundamental Analysis

Industry Biotechnology
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EPRX with price predictions
Jan 08, 2025

EPRX in +2.92% Uptrend, growing for three consecutive days on December 31, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EPRX advanced for three days, in of 28 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 30 cases where EPRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

EPRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EPRX as a result. In of 42 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EPRX moved below its 50-day moving average on January 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EPRX crossed bearishly below the 50-day moving average on January 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EPRX entered a downward trend on January 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.976) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). EPRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EPRX is expected to report earnings to rise 2.89% to -12 cents per share on April 01

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of -12 cents, beating the estimate of -12 cents. With 583.00 shares outstanding, the current market capitalization sits at 114.56M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201-2067 Cadboro Bay Road
Phone
+1 250 590-3968
Employees
21
Web
https://www.eupraxiapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IESGX22.510.21
+0.94%
Sit ESG Growth I
MKVGX13.280.08
+0.61%
MFS International Large Cap Value R4
WSBFX22.600.13
+0.58%
Boston Trust Walden Balanced
TSMOX15.210.07
+0.46%
Nuveen Quant Small/Mid Cap Eq Retirement
GPGIX3.390.01
+0.30%
Grandeur Peak Global Opportunities Instl

EPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with CRBU. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+6.31%
CRBU - EPRX
41%
Loosely correlated
-0.65%
ACAD - EPRX
27%
Poorly correlated
+0.29%
KRON - EPRX
21%
Poorly correlated
-1.92%
ATHA - EPRX
21%
Poorly correlated
-0.09%
TYRA - EPRX
21%
Poorly correlated
+0.25%
More